Proteins derived from neutrophil extracellular traps may serve as self-antigens and mediate organ damage in autoimmune diseases

Frontiers in Immunology

Volumn 3, Issue DEC, 2012, Pages

  Knight, Jason S ^a   Carmona Rivera, Carmelo ^a   Kaplan, Mariana J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Autoimmunity; Citrullination; NETs; Neutrophil; Posttranslational modifications; Psoriasis; Systemic lupus erythematosus (SLE); Vasculitis

Indexed keywords

EID: 84874228952     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00380     Document Type: Review

References (143)

1. Abdulahad, D. A., Westra, J., Bijzet, J., Dolff, S., Van Dijk, M. C., Limburg, P. C., et al. (2012). Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations. Arthritis Res. Ther. 14:R184. doi: 10.1186/ar4015
2. Abdulahad, D. A., Westra, J., Limburg, P. C., Kallenberg, C. G., and Bijl, M. (2010). HMGB1 in systemic lupus Erythematosus: its role in cutaneous lesions development. Autoimmun. Rev. 9, 661-665.
3. Abramson, S. B., Given, W. P., Edelson, H. S., and Weissmann, G. (1983). Neutrophil aggregation induced by sera from patients with active systemic lupus erythematosus. Arthritis Rheum. 26, 630-636.
4. Abreu-Velez, A. M., Smith, J. G. Jr., and Howard, M. S. (2009). Presence of neutrophil extracellular traps and antineutrophil cytoplasmic antibodies associated with vasculitides. N. Am. J. Med. Sci. 1, 309-313.
5. Adeyemi, E. O., Campos, L. B., Loizou, S., Walport, M. J., and Hodgson, H. J. (1990). Plasma lactoferrin and neutrophil elastase in rheumatoid arthritis and systemic lupus erythematosus. Br. J. Rheumatol. 29, 15-20.
6. Austin, H. A. 3rd., Muenz, L. R., Joyce, K. M., Antonovych, T. T., and Balow, J. E. (1984). Diffuse prolif-erative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int. 25, 689-695.
7. Baechler, E. C., Batliwalla, F. M., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., et al. (2003). Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. U.S.A. 100,2610-2615.
8. Balint, G. P., and Balint, P. V. (2004). Felty's syndrome. Best Pract. Res. Clin. Rheumatol. 18, 631-645.
9. Banchereau, J., and Pascual, V. (2006). Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity25, 383-392.
10. Barkauskaite, V., Ek, M., Popovic, K., Harris, H. E., Wahren-Herlenius, M., and Nyberg, F. (2007). Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus. Lupus 16, 794-802.
11. Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., et al. (2003). Interferon and gran-ulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197,711-723.
12. Bianchi, M., Niemiec, M. J., Siler, U., Urban, C. F., and Reichenbach, J. (2011). Restoration of anti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent. J. Allergy Clin. Immunol. 127, 1243-1252. e1247.
13. Brandt, L., and Hedberg, H. (1969). Impaired phagocytosis by peripheral blood granulocytes in systemic lupus erythematosus. Scand. J. Haematol. 6, 348-353.
14. Brill, A., Fuchs, T. A., Savchenko, A., Thomas, G. M., Martinod, K., De Meyer, S. F., et al. (2012). Neutrophil extracellular traps promote deep vein thrombosis in mice. J. Thromb. Haemost. 10, 136-144.
15. Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., et al. (2004). Neutrophil extracellular traps kill bacteria. Science 303, 1532-1535.
16. Brinkmann, V., and Zychlinsky, A. (2012). Neutrophil extracellular traps: is immunity the second function of chromatin? J. Cell Biol. 198, 773-783.
17. Caccavo, D., Rigon, A., Picardi, A., Galluzzo, S., Vadacca, M., Ferri, G. M., et al. (2005). Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates. Clin. Rheumatol. 24, 381-387.
18. Cambridge, G., Wallace, H., Bernstein, R. M., and Leaker, B. (1994). Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis. Br. J. Rheumatol. 33, 109-114.
19. Casciola-Rosen, L., Andrade, F., Ulanet, D., Wong, W. B., and Rosen, A. (1999). Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J. Exp. Med. 190, 815-826.
20. Caudrillier, A., Kessenbrock, K., Gilliss, B. M., Nguyen, J. X., Marques, M. B., Monestier, M., et al. (2012). Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J. Clin. Invest. 122, 2661-2671.
21. Chen, M., and Kallenberg, C. G. (2009). New advances in the pathogenesis of ANCA-associated vasculitides. Clin. Exp. Rheumatol. 27, S108-S114.
22. Clark, S. R., Ma, A. C., Tavener, S. A., McDonald, B., Goodarzi, Z., Kelly, M. M., et al. (2007). Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13,463-469.
23. Cohen, M. G., and Webb, J. (1989). Antihistone antibodies in rheumatoid arthritis and Felty's syndrome. Arthritis Rheum. 32, 1319-1324.
24. Courtney, P. A., Crockard, A. D., Williamson, K., Irvine, A. E., Kennedy, R. J., and Bell, A. L. (1999). Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann. Rheum. Dis. 58, 309-314.
25. Crispin, J. C., Kyttaris, V. C., Terhorst, C., and Tsokos, G. C. (2010). T cells as therapeutic targets in SLE. Nat. Rev. Rheumatol. 6, 317-325.
26. Denny, M. F., Yalavarthi, S., Zhao, W., Thacker, S. G., Anderson, M., Sandy, A. R., et al. (2010). A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs.J. Immunol. 184, 3284-3297.
27. Dieker, J., and Muller, S. (2010). Epigenetic histone code and autoimmunity. Clin. Rev. Allergy Immunol. 39, 78-84.
28. Dieker, J. W., Fransen, J. H., Van Bavel, C. C., Briand, J. P., Jacobs, C. W., Muller, S., et al. (2007). Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus. Arthritis Rheum. 56, 1921-1933.
29. Dorner, T., Jacobi, A. M., Lee, J., and Lipsky, P. E. (2011). Abnormalities of B cell subsets in patients with systemic lupus erythematosus. J. Immunol. Methods 363, 187-197.
30. Dubois, A. V., Gauthier, A., Brea, D., Varaigne, F., Diot, P., Gauthier, F., et al. (2012). Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum. Am. J. Respir. Cell Mol. Biol. 47, 80-86.
31. Duskin, A., and Eisenberg, R. A. (2010). The role of antibodies in inflammatory arthritis. Immunol. Rev. 233, 112-125.
32. Dwivedi, N., Upadhyay, J., Neeli, I., Khan, S., Pattanaik, D., Myers, L., et al. (2012). Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps. Arthritis Rheum. 64, 982-992.
33. Elkon, K. B., and Stone, V V (2011). Type I interferon and systemic lupus erythematosus. J. Interferon CytokineRes. 31,803-812.
34. Ermert, D., Urban, C. F., Laube, B., Goosmann, C., Zychlinsky, A., and Brinkmann, V (2009). Mouse neutrophil extracellular traps in micro-bial infections. J. Innate Immun. 1, 181-193.
35. Foulquier, C., Sebbag, M., Clavel, C., Chapuy-Regaud, S., Al Badine, R., Mechin, M. C., et al. (2007). Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum. 56, 3541-3553.
36. Froy, O., and Sthoeger, Z. M. (2009). Defensins in systemic lupus erythematosus. Ann. N.Y. Acad. Sci. 1173, 365-369.
37. Fuchs, T. A., Abed, U., Goosmann, C., Hurwitz, R., Schulze, I., Wahn, V., et al. (2007). Novel cell death program leads to neutrophil extracellular traps.J. Cell Biol. 176,231-241.
38. Fuchs, T. A., Brill, A., Duerschmied, D., Schatzberg, D., Monestier, M., Myers, D. D. Jr., et al. (2010). Extracellular DNA traps promote thrombosis. Proc. Natl. Acad. Sci. U.S.A. 107, 15880-15885.
39. Galeazzi, M., Morozzi, G., Sebastiani, G. D., Bellisai, F., Marcolongo, R., Cervera, R., et al. (1998). Antineutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European Concerted Action on the Immunogenetics of SLE. Clin. Exp. Rheumatol. 16, 541-546.
40. Ganguly, D., Chamilos, G., Lande, R., Gregorio, J., Meller, S., Facchinetti, V., et al. (2009). Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J. Exp. Med. 206, 1983-1994.
41. Garcia-Romo, G. S., Caielli, S., Vega, B., Connolly, J., Allantaz, F., Xu, Z., et al. (2011). Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 3:73ra20. doi: 10.1126/sci-translmed.3001201
42. Graham, K. L., and Utz, P. J. (2005). Sources of autoantigens in systemic lupus erythematosus. Curr. Opin. Rheumatol. 17,513-517.
43. Gupta, A. K., Joshi, M. B., Philippova, M., Erne, P., Hasler, P., Hahn, S., et al. (2010). Activated endothe-lial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death. FEBS Lett. 584,3193-3197.
44. Hacbarth, E., and Kajdacsy-Balla, A. (1986). Low density neutrophils in patients with systemic lupus erythematosus, rheumatoid arthritis, and acute rheumatic fever. Arthritis Rheum. 29, 1334-1342.
45. Haga, H. J., Brun, J. G., Berntzen, H. B., Cervera, R., Khamashta, M., and Hughes, G. R. (1993). Calprotectin in patients with systemic lupus erythematosus: relation to clinical and laboratory parameters of disease activity. Lupus 2, 47-50.
46. Hakkim, A., Fuchs, T. A., Martinez, N. E., Hess, S., Prinz, H., Zychlinsky, A., et al. (2011). Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation. Nat. Chem. Biol. 7, 75-77.
47. Hakkim, A., Furnrohr, B. G., Amann, K., Laube, B., Abed, U. A., Brinkmann, V., et al. (2010). Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc. Natl. Acad. Sci. U.S.A. 107, 9813-9818.
48. Hashimoto, Y., Ziff, M., and Hurd, E. R. (1982). Increased endothelial cell adherence, aggregation, and super-oxide generation by neutrophils incubated in systemic lupus erythematosus and Felty's syndrome sera. Arthritis Rheum. 25, 1409-1418.
49. Hemmers, S., Teijaro, J. R., Arandjelovic, S., and Mowen, K. A. (2011). PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection. PLoS ONE 6:e22043. doi: 10.1371/journal.pone.0022043
50. Henson, P. M. (1972). Pathologic mechanisms in neutrophil-mediated injury. Am. J. Pathol. 68,593-612.
51. Hirsch, J. G. (1958). Bactericidal action of histone. J. Exp. Med. 108, 925-944.
52. Hotta, O., Oda, T., Taguma, Y., Kitamura, H., Chiba, S., Miyazawa, S., et al. (1996). Role of neutrophil elastase in the development of renal necrotizing vasculitis. Clin. Nephrol. 45,211-216.
53. Johnson, R. J., Couser, W. G., Alpers, C. E., Vissers, M., Schulze, M., and Klebanoff, S. J. (1988). The human neutrophil serine proteinases, elastase and cathepsin G, can mediate glomerular injury in vivo. J. Exp. Med. 168, 1169-1174.
54. Jonsson, H., and Sturfelt, G. (1990). A novel assay for neutrophil clustering activity of human sera: relation to disease activity and neutropenia in systemic lupus erythematosus. Ann. Rheum. Dis. 49, 46-50.
55. Kadowaki, N., Ho, S., Antonenko, S., Malefyt, R. W., Kastelein, R. A., Bazan, F., et al. (2001). Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens.J. Exp. Med. 194, 863-869.
56. Kaplan, M. J. (2011). Neutrophils in the pathogenesis and manifestations of SLE. Nat. Rev. Rheumatol. 7, 691-699.
57. Kaplan, M. J., and Radic, M. (2012). Neutrophil extracellular traps: double-edged swords of innate immunity. J. Immunol. 189, 2689-2695.
58. Kessenbrock, K., Krumbholz, M., Schonermarck, U., Back, W., Gross, W. L., Werb, Z., et al. (2009). Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 15, 623-625.
59. Kilsgard, O., Andersson, P., Malmsten, M., Nordin, S. L., Linge, H. M., Eliasson, M., et al. (2012). Peptidylarginine deiminases present in the airways during tobacco smoking and inflammation can citrullinate the host defense peptide LL-37, resulting in altered activities. Am. I Respir. Cell Mol. Biol. 46, 240-248.
60. Knight, J. S., and Kaplan, M. J. (2012). Lupus neutrophils: 'NET' gain in understanding lupus pathogenesis. Curr. Opin. Rheumatol. 24, 441-450.
61. Kobayashi, S. D., and Deleo, E R. (2009). Role of neutrophils in innate immunity: a systems biology-level approach. Wiley Interdiscip. Rev. Syst. Biol. Med. 1, 309-333.
62. Kryczek, I., Bruce, A. T., Gudjonsson, J. E., Johnston, A., Aphale, A., Vatan, L., et al. (2008). Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J. Immunol. 181, 4733-4741.
63. Lande, R., Ganguly, D., Facchinetti, V., Frasca, L., Conrad, C., Gregorio, J., et al. (2011). Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med. 3:73ra19. doi: 10.1126/scitranslmed.3001180
64. Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y. H., Homey, B., et al. (2007). Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449, 564-569.
65. Lee, S. S., Lawton, J. W., Chan, C. E., Li, C. S., Kwan, T. H., and Chau, K. F. (1992). Antilactoferrin antibody in systemic lupus erythematosus. Br. I Rheumatol. 31,669-673.
66. Leffler, J., Martin, M., Gullstrand, B., Tyden, H., Lood, C., Truedsson, L., et al. (2012). Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J. Immunol. 188, 3522-3531.
67. Lehrer, R. I., and Ganz, T. (2002). Defensins of vertebrate animals. Curr. Opin. Immunol. 14, 96-102.
68. Lehrer, R. I., Lichtenstein, A. K., and Ganz, T. (1993). Defensins: antimicrobial and cytotoxic pep-tides of mammalian cells. Annu. Rev. Immunol. 11, 105-128.
69. Li, P., Li, M., Lindberg, M. R., Kennett, M. J., Xiong, N., and Wang, Y. (2010). PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J. Exp. Med. 207, 1853-1862.
70. Lin, A. M., Rubin, C. J., Khandpur, R., Wang, J. Y., Riblett, M., Yalavarthi, S., et al. (2011). Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J.Immunol. 187,490-500.
71. Liu, C. L., Tangsombatvisit, S., Rosenberg, J. M., Mandelbaum, G., Gillespie, E. C., Gozani, O. P., et al. (2012). Specific post-translational histone modifications of neutrophil extracellular traps as immunogens and potential targets of lupus autoantibodies. Arthritis Res. Ther. 14:R25. doi: 10.1186/ar3707
72. Liu, X., and Loughran, T. P. Jr. (2011). The spectrum of large granular lymphocyte leukemia and Felty's syndrome. Curr. Opin. Hematol. 18, 254-259.
73. Lowes, M. A., Kikuchi, T., Fuentes-Duculan, J., Cardinale, I., Zaba, L. C., Haider, A. S., et al. (2008). Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J. Invest. Dermatol. 128, 1207-1211.
74. Luger, K., Mader, A. W., Richmond, R. K., Sargent, D. F., and Richmond, T. J. (1997). Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389, 251-260.
75. Lundberg, K., Nijenhuis, S., Vossenaar, E. R., Palmblad, K., Van Venrooij, W. J., Klareskog, L., et al. (2005). Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res. Ther. 7, R458-R467.
76. Ma, C. Y., Jiao, Y L., Zhang, J., Yang, Q. R., Zhang, Z. F., Shen, Y J., et al. (2012). Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-alpha and TNF-alpha in systemic lupus erythematosus. Rheumatol. Int. 32, 395-402.
77. Manolova, I., Dancheva, M., and Halacheva, K. (2001). Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations. Rheumatol. Int. 20, 197-204.
78. Mansour, R. B., Lassoued, S., Gargouri, B., El Gaid, A., Attia, H., and Fakhfakh, F. (2008). Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus. Scand. I Rheumatol. 37, 103-108.
79. Martinelli, S., Urosevic, M., Daryadel, A., Oberholzer, P. A., Baumann, C., Fey, M. F., et al. (2004). Induction of genes mediating interferon-dependent extracellular trap formation during neutrophil differentiation. J. Biol. Chem. 279, 44123-44132.
80. Martinon, F., Petrilli, V., Mayor, A., Tardivel, A., and Tschopp, J. (2006). Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237-241.
81. Mastronardi, F. G., Wood, D. D., Mei, J., Raijmakers, R., Tseveleki, V., Dosch, H. M., et al. (2006). Increased cit-rullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 transloca-tion.J. Neurosci. 26, 11387-11396.
82. Metzler, K. D., Fuchs, T. A., Nauseef, W M., Reumaux, D., Roesler, J., Schulze, I., et al. (2011). Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity. Blood 117, 953-959.
83. Mitroulis, I., Kambas, K., Chrysanthopoulou, A., Skendros, P., Apostolidou, E., Kourtzelis, I., et al. (2011). Neutrophil extracellular trap formation is associated with IL-1beta and autophagy-related signaling in gout. PLoS ONE 6:e29318. doi: 10.1371/journal.pone.0029318
84. Molad, Y., Buyon, J., Anderson, D. C., Abramson, S. B., and Cronstein, B. N. (1994). Intravascular neutrophil activation in systemic lupus erythematosus (SLE): dissociation between increased expression of CD11b/CD18 and diminished expression of L-selectin on neutrophils from patients with active SLE. Clin. Immunol. Immunopathol. 71,281-286.
85. Monestier, M., Decker, P., Briand, J. P., Gabriel, J. L., and Muller, S. (2000). Molecular and structural properties of three autoimmune IgG monoclonal antibodies to histone H2B. J. Biol. Chem. 275, 13558-13563.
86. Mosca, M., Chimenti, D., Pratesi, F., Baldini, C., Anzilotti, C., Bombardieri, S., et al. (2006). Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus. J. Rheumatol. 33, 695-697.
87. Nakazawa, D., Tomaru, U., Suzuki, A., Masuda, S., Hasegawa, R., Kobayashi, T., et al. (2012). Abnormal conformation and impaired degradation of NETs induced by propylthiouracil: implication of disordered NETs in MPO-ANCA-associated vasculitis. Arthritis Rheum. 64, 3779-3787.
88. Nassberger, L., Jonsson, H., Sjoholm, A. G., Sturfelt, G., and Heubner, A. (1989). Circulating anti-elastase in systemic lupus erythematosus. Lancet 1, 509.
89. Nassberger, L., Sjoholm, A. G., Jonsson, H., Sturfelt, G., and Akesson, A. (1990). Autoantibodies against neu-trophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus. Clin. Exp. Immunol. 81, 380-383.
90. Neeli, I., Dwivedi, N., Khan, S., and Radic, M. (2009). Regulation of extracellular chromatin release from neutrophils. J. Innate Immun. 1, 194-201.
91. Neeli, I., Khan, S. N., and Radic, M. (2008). Histone deimination as a response to inflammatory stimuli in neutrophils. J. Immunol. 180, 1895-1902.
92. Nestle, F. O., Conrad, C., Tun-Kyi, A., Homey, B., Gombert, M., Boyman, O., et al. (2005). Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.J. Exp. Med. 202, 135-143.
93. Nishinaka, Y., Arai, T., Adachi, S., Takaori-Kondo, A., and Yamashita, K. (2011). Singlet oxygen is essential for neutrophil extracellular trap formation. Biochem. Biophys. Res. Commun. 413, 75-79.
94. Palmer, L. J., Cooper, P. R., Ling, M. R., Wright, H. J., Huissoon, A., and Chapple, I. L. (2012). Hypochlorous acid regulates neutrophil extracellular trap release in humans. Clin. Exp. Immunol. 167, 261-268.
95. Pan, H. F., Fang, X. H., Wu, G. C., Li, W. X., Zhao, X. F., Li, X. P., et al. (2008). Anti-neutrophil cyto-plasmic antibodies in new-onset systemic lupus erythematosus and lupus nephritis. Inflammation 31, 260-265.
96. Pan, H. F., Wu, G. C., Li, W. P., Li, X. P., and Ye, D. Q. (2010). High Mobility Group Box 1: a potential therapeutic target for systemic lupus erythematosus. Mol. Biol. Rep. 37, 1191-1195.
97. Papayannopoulos, V., Metzler, K. D., Hakkim, A., and Zychlinsky, A. (2010). Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps.J. Cell Biol. 191,677-691.
98. Pfister, H., Ollert, M., Frohlich, L. F., Quintanilla-Martinez, L., Colby, T. V., Specks, U., et al. (2004). Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo. Blood 104, 1411-1418.
99. Pisetsky, D. S. (2012). HMGB1: a smoking gun in lupus nephritis? Arthritis Res. Ther. 14:112. doi: 10.1186/ar3754
100. Popa-Nita, O., and Naccache, P. H. (2010). Crystal-induced neutrophil activation. Immunol. Cell Biol. 88, 32-40.
101. Popovic, K., Ek, M., Espinosa, A., Padyukov, L., Harris, H. E., Wahren-Herlenius, M., et al. (2005). Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum. 52, 3639-3645.
102. Price, J. V., Tangsombatvisit, S., Xu, G., Yu, J., Levy, D., Baechler, E. C., et al. (2012). On silico pep-tide microarrays for high-resolution mapping of antibody epitopes and diverse protein-protein interactions. Nat. Med. 18, 1434-1440.
103. Remijsen, Q., Vanden Berghe, T., Wirawan, E., Asselbergh, B., Parthoens, E., De Rycke, R., et al. (2011). Neutrophil extracellular trap cell death requires both autophagy and superoxide generation. CellRes. 21, 290-304.
104. Robinson, W. H., Digennaro, C., Hueber, W., Haab, B. B., Kamachi, M., Dean, E. J., et al. (2002). Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med. 8,295-301.
105. Rosen, A., and Casciola-Rosen, L. (1999). Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ. 6, 6-12.
106. Saffarzadeh, M., Juenemann, C., Queisser, M. A., Lochnit, G., Barreto, G., Galuska, S. P., et al. (2012). Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of his-tones. PLoS ONE 7:e32366. doi: 10.1371/journal.pone.0032366
107. Sangaletti, S., Tripodo, C., Chiodoni, C., Guarnotta, C., Cappetti, B., Casalini, P., et al. (2012). Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells towards ANCA induction and associated autoimmunity. Blood 120, 3007-3018
108. Schellekens, G. A., Visser, H., De Jong, B. A., Van Den Hoogen, E H., Hazes, J. M., Breedveld, E C., et al. (2000). The diagnostic properties of rheumatoid arthritis antibodies rec ognizing a cyclic citrullinated pep- tide. Arthritis Rheum. 43, 155-163.
109. Schorn, C., Janko, C., Latzko, M., Chaurio, R., Schett, G., and Herrmann, M. (2012). Monosodium urate crystals induce extracellular DNA traps in neutrophils, eosinophils, and basophils but not in mononuclear cells. Front. Immun. 3:277. doi: 10.3389/fimmu.2012.00277
110. Shin, H. D., Park, B. L., Kim, L. H., Lee, H. S., Kim, T. Y., and Bae, S. C. (2004). Common DNase I polymorphism associated with autoantibody production among systemic lupus erythematosus patients. Hum. Mol. Genet. 13,2343-2350.
111. Skrzeczynska-Moncznik, J., Wlodarczyk, A., Zabieglo, K., Kapinska-Mrowiecka, M., Marewicz, E., Dubin, A., et al. (2012). Secretory leukocyte proteinase inhibitor-competent DNA deposits are potent stimulators of plasmacytoid dendritic cells: implication for psoriasis.J. Immunol. 189, 1611-1617.
112. Sthoeger, Z. M., Bezalel, S., Chapnik, N., Asher, I., and Froy, O. (2009). High alpha-defensin levels in patients with systemic lupus erythematosus. Immunology 127, 116-122.
113. Suzuki, A., Yamada, R., Chang, X., Tokuhiro, S., Sawada, T., Suzuki, M., et al. (2003). Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat. Genet. 34, 395-402.
114. Suzuki, T., Burlingame, R. W., Casiano, C A., Boey, M. L., and Rubin, R. L. (1994). Antihistone antibod ies in systemic lupus erythemato sus: assay dependency and effects of ubiquitination and serum DNA. J. Rheumatol. 21, 1081-1091.
115. Tamiya, H., Tani, K., Miyata, J., Sato, K., Urata, T., Lkhagvaa, B., et al. (2006). Defensins- and cathepsin G-ANCA in systemic lupus erythematosus. Rheumatol. Int. 27, 147-152.
116. Tan, E. M., Schur, P. H., Carr, R. I., and Kunkel, H. G. (1966). Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J. Clin. Invest. 45, 1732-1740.
117. Telles, R. W., Ferreira, G. A., Da Silva, N. P., and Sato, E. I. (2010). Increased plasma myeloperoxidase levels in systemic lupus erythematosus. Rheumatol. Int. 30, 779-784.
118. Thomas, G. M., Carbo, C., Curtis, B. R., Martinod, K., Mazo, I. B., Schatzberg, D., et al. (2012). Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice. Blood 119,6335-6343.
119. Tian, J., Avalos, A. M., Mao, S. Y., Chen, B., Senthil, K., Wu, H., et al. (2007). Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8, 487-496.
120. Tsai, W J., Liu, H. W., Yen, J. H., Chen, J. R., Lin, S. F., and Chen, T. P. (1991). Lactoferrin in rheumatoid arthritis and systemic lupus erythe-matous. Gaoxiong Yi Xue Ke Xue Za Zhi 7, 22-26.
121. Tsokos, G. C. (2011). Systemic lupus erythematosus. N Engl. J. Med. 365, 2110-2121.
122. Tuaillon, N., Muller, S., Pasquali, J. L., Bordigoni, P., Youinou, P., and Van Regenmortel, M. H. (1990). Antibodies from patients with rheumatoid arthritis and juvenile chronic arthritis analyzed with core histone synthetic peptides. Int. Arch. Allergy Appl. Immunol. 91, 297-305.
123. Urban, C. F., Ermert, D., Schmid, M., Abu-Abed, U., Goosmann, C., Nacken, W., et al. (2009). Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog. 5:e1000639. doi: 10.1371/journal.ppat.1000639
124. Urbonaviciute, V., Furnrohr, B. G., Meister, S., Munoz, L., Heyder, P., De Marchis, F., et al. (2008). Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J. Exp. Med. 205, 3007-3018.
125. Urbonaviciute, V., and Voll, R. E. (2011). High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus. J. Intern. Med. 270, 309-318.
126. Utz, P. J., Gensler, T. J., and Anderson, P. (2000). Death, autoantigen modifications, and tolerance. Arthritis Res. 2, 101-114.
127. Van Bavel, C. C., Dieker, J., Muller, S., Briand, J. P., Monestier, M., Berden, J. H., et al. (2009). Apoptosis-associated acetyla-tion on histone H2B is an epitope for lupus autoantibodies. Mol. Immunol. 47,511-516.
128. Van Bavel, C. C., Dieker, J. W., Kroeze, Y., Tamboer, W. P., Voll, R., Muller, S., et al. (2011). Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus. Ann. Rheum. Dis. 70,201-207.
129. Villanueva, E., Yalavarthi, S., Berthier, C. C., Hodgin, J. B., Khandpur, R., Lin, A. M., et al. (2011). Netting neutrophils induce endothe-lial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J. Immunol. 187, 538-552.
130. Vordenbaumen, S., Fischer-Betz, R., Timm, D., Sander, O., Chehab, G., Richter, J., et al. (2010). Elevated levels of human beta-defensin 2 and human neutrophil peptides in systemic lupus erythematosus. Lupus 19, 1648-1653.
131. Vordenbaumen, S., Sander, O., Bleck, E., Schneider, M., and Fischer-Betz, R. (2012). Cardiovascular disease and serum defensin levels in systemic lupus erythematosus. Clin. Exp. Rheumatol. 30, 364-370.
132. Vossenaar, E. R., Zendman, A. J., Van Venrooij, W. J., and Pruijn, G. J. (2003). Pad, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 25, 1106-1118.
133. Wada, N., Mukai, M., Kohno, M., Notoya, A., Ito, T., and Yoshioka, N. (2002). Prevalence of serum anti-myeloperoxidase antineu-trophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease treated with propy-lthiouracil and thiamazole. Endocr. J. 49, 329-334.
134. Wahren, M., Brun, J. G., Jonsson, R., and Haga, H. J. (1995). Autoantibodies to calprotectin are not found in patients with systemic lupus erythematosus or other inflammatory rheumatic diseases. Lupus 4, 498.
135. Wang, Y., Li, M., Stadler, S., Correll, S., Li, P., Wang, D., et al. (2009). Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J. Cell Biol. 184, 205-213.
136. Wegner, N., Lundberg, K., Kinloch, A., Fisher, B., Malmstrom, V., Feldmann, M., et al. (2010). Autoimmunity to specific citrul-linated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol. Rev. 233, 34-54.
137. Wilson, N. J., Boniface, K., Chan, J. R., McKenzie, B. S., Blumenschein, W. M., Mattson, J. D., et al. (2007). Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8, 950-957.
138. Xiao, H., Heeringa, P., Hu, P., Liu, Z., Zhao, M., Aratani, Y., et al. (2002). Antineutrophil cytoplasmic autoantibodies specific for myeloperoxi-dase cause glomerulonephritis and vasculitis in mice.J. Clin. Invest. 110, 955-963.
139. Yasutomo, K., Horiuchi, T., Kagami, S., Tsukamoto, H., Hashimura, C., Urushihara, M., et al. (2001). Mutation of DNASE1 in people with systemic lupus erythematosus. Nat. Genet. 28, 313-314.
140. Yoneda, M., Fujii, A., Ito, A., Yokoyama, H., Nakagawa, H., and Kuriyama, M. (2007). High prevalence of serum autoantibodies against the amino terminal of alpha-enolase in Hashimoto's encephalopa-thy. J. Neuroimmunol. 185, 195-200.
141. Zhang, X. H., Yan, Y H., Liang, Z. Q., Cui, X. L., and Jiang, M. (1989). Changes of neutrophil elas-tase and alpha 1-antitrypsin in systemic lupus erythematosus. Proc. Chin. Acad. Med. Sci. Peking Union Med. Coll. 4, 26-29.
142. Zhao, M. H., Liu, N., Zhang, Y. K., and Wang, H. Y (1998). Antineutrophil cytoplasmic autoantibodies (ANCA) and their target antigens in Chinese patients with lupus nephritis. Nephrol. Dial. Transplant. 13,2821-2824.
143. Zickert, A., Palmblad, K., Sundelin, B., Chavan, S., Tracey, K. J., Bruchfeld, A., et al. (2012). Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis. Arthritis Res. Ther. 14:R36. doi: 10.1186/ar3747